Ahmed A Shaaban
Overview
Explore the profile of Ahmed A Shaaban including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmed H, Shaaban A, Ibrahim T, Makled M
Food Chem Toxicol
. 2024 Nov;
194:115079.
PMID: 39491767
Gender contributes to differences in incidence and progression of chronic kidney disease (CKD) post-cisplatin therapy. This study aims at investigating the potential effect of G1 compound, a GPER agonist, on...
2.
Ahmed H, Shaaban A, Makled M, Ibrahim T
Chem Biol Interact
. 2024 May;
398:111065.
PMID: 38795875
Multiple cycles of cisplatin result in a permanent loss of kidney function with severe and life-limited chronic kidney disease (CKD) after successful cisplatin therapy. Recently, studies have showed that the...
3.
Shaker M, Gomaa H, Hazem S, Abdelgawad M, El-Mesery M, Shaaban A
Front Pharmacol
. 2023 Sep;
14:1281416.
PMID: 37745058
[This corrects the article DOI: 10.3389/fphar.2023.1212771.].
4.
Shaker M, Gomaa H, Hazem S, Abdelgawad M, El-Mesery M, Shaaban A
Front Pharmacol
. 2023 Aug;
14:1212771.
PMID: 37608890
The sterile inflammatory response mediated by Toll-like receptors (TLRs) 4 and 9 is implicated in the massive hepatic damage caused by acetaminophen (APAP)-overdose. There is a crosstalk between TLR-dependent signaling...
5.
Shaaban A, Khalaf E, Hazem S, Shaker M, Shata A, Nouh N, et al.
Life Sci
. 2023 Jul;
331:121931.
PMID: 37442416
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can...
6.
Ali Y, Lynch N, Shaaban A, Rizk D, Abdel-Rahman S, Khatri P, et al.
Front Immunol
. 2023 Jun;
14:1192767.
PMID: 37325666
Acute respiratory distress syndrome (ARDS) is a life-threatening disorder with a high rate of mortality. Complement activation in ARDS initiates a robust inflammatory reaction that can cause progressive endothelial injury...
7.
Shaker M, Gomaa H, Abdelgawad M, El-Mesery M, Shaaban A, Hazem S
Int Immunopharmacol
. 2023 May;
120:110373.
PMID: 37257270
Inflammation has been convicted of causing and worsening many liver diseases like acute liver failure, fibrosis, cirrhosis, fatty liver and liver cancer. Pattern recognition receptors (PRRs) like TLRs 4 and...
8.
Saleh M, Shaaban A, Talaat I, Elmougy A, Adra S, Ahmad F, et al.
Life Sci
. 2023 Apr;
323:121687.
PMID: 37030613
Endothelin-1 (ET-1) contributes to the development of kidney diseases. However, the underlying molecular mechanism is largely undefined. Here we sought to investigate the potential role of ET-1 receptors, ET and...
9.
Shaaban A, Zaghloul R, Kafl H, El-Kashef D
Life Sci
. 2023 Jan;
316:121441.
PMID: 36709911
Aims: This study was mapped to investigate the potential effects of desloratadine (DES) against CIS-induced nephrotoxicity and testicular injury. Main Methods: DES (5 and 10 mg/kg) was orally administered for...
10.
Shaaban A, Abdelhamid A, Shaker M, Cavalu S, Maghiar A, Alsayegh A, et al.
Biomed Pharmacother
. 2022 Jun;
153:113247.
PMID: 35724510
Ulcerative colitis (UC) is a prevalent type of inflammatory bowel diseases that may predispose patients to acquire colitis-related cancer if treatment was not effective. Despite the presence of an array...